The Cameron Institute was founded in 2009 as an alternative, not-for-profit, public policy think tank specializing in the independent study of health, social and economic issues both in Canada and around the world. It is governed by a volunteer board of directors representative of the scientific, clinical and policy sectors.
The Cameron Institute’s values are best summarized in three words: freedom, choice and responsibility.
In 2009, Dr. Wayne Taylor was appointed the Executive Director of The Cameron Institute where he is dedicated to improving public access to medical therapies.
Founding Chair of the Board Don Ford is a seasoned health executive having served in the health field for more than 30 years. Don’s career began at Chedoke-McMaster Hospitals in Hamilton, Ontario in 1973, starting as a Child and Family Therapist and then assuming positions of increasing administrative responsibility culminating in the position of Administrator, […]
Board Member Dr. MacLeod is Executive Director, Child & Family Research Institute, Professor, Pediatrics and Associate Dean (Research), Faculty of Medicine, University of British Columbia, and Vice President Academic Liaison & Research Coordination for the Provincial Health Services Authority. Before moving to Vancouver, he was Professor, Clinical Epidemiology and Biostatistics, Pediatrics, and Medicine at McMaster […]
Board Member Mike Cloutier is an accomplished business leader and consultant with over 27 years in the Life Sciences sectors. With a strong track record of accomplishments and through his thoughtful approach to leadership at all levels of the organization, Mike has established an extensive network of colleagues and clients.
Board Member Peter Brenders General Manager, Genzyme, a Sanofi Company Prior to his most recent appointment at Genzyme, Peter Brenders was President & CEO of BIOTECanada since 2005. Previously, he worked in health and corporate affairs in senior management roles at Genzyme Canada and Schering-Plough Canada. Mr. Brenders also sits on various boards in the […]
Theresa has extensive expertise in pharmaceuticals and healthcare management with 15 years in progressively senior roles at Pfizer Inc. and more than 10 years in the Government healthcare sector. Theresa has international experience in leadership roles in Canada, Europe and Asia. She is a Corporate Director for Merus Labs International (TSE: MSL) and has held […]
Sheila Frame is a strategic, dynamic and high-energy executive with a proven track record of success in the pharmaceutical industry and an accomplished lobbyist in both healthcare and transportation. A seasoned industry spokesperson recognized as a passionate and inspiring leader, she has served as an elected and appointed board member in the not-for-profit education space. […]
John Bachynsky’s initial career was in hospital pharmacy and academia, then to the Department of National Health and Welfare where for many years he was involved in Federal/Provincial projects, drug price concerns, and served as a pharmacy consultant for provincial and international projects. Served as Acting ADM of Long Range Health Planning just before going back […]
Research Associate Dr. Kristina M. Lybecker is an Assistant Professor of Economics at Colorado College in Colorado Springs. She earned a B.A. from Macalester College, with a double major in Economics and Latin American Studies, and received her Ph.D. in Economics in 2000 from the University of California, Berkeley. Prior to accepting her position at […]
Research Associate Dr. Michael J. Rieder is a Professor of Paediatrics, Physiology & Pharmacology and Medicine at the University of Western Ontario. He holds the holds the CIHR-GSK Chair in Paediatric Clinical Pharmacology at the University of Western Ontario. He is also the Program Director of the Clinical Investigators Program and the Director of Paediatric […]
Research Associate Mr. Heenan is the Director of Quality Performance & Risk Management at the Credit Valley Hospital, a 400-bed community hospital in the city of Mississauga. Mike’s responsibilities include clinical and operational planning, dissemination of key clinical and utilization resource data, patient safety and quality improvement. Recent accomplishments include the launch of quarterly utilization […]
Research Associate Robert Freeman was one of the first leaders in health economics and outcomes research in the global pharmaceutical industry. He has directed and conducted comparative effectiveness research across a diverse portfolio of developmental and marketed products from preclinical to patent expiration in North American, Europe, Japan, and emerging country markets. He brings over […]
Patient Associate Harlon has a B.A. in Economics from the University of Waterloo when he was young and didn’t have a clue what he wanted to do. He returned to education later in life to start a a B.Sc. in Zoology but instead but the Master’s of Forest Conservation both from the University of Toronto. […]
Policy Associate In Jeff Heatherington, the osteopathic physicians and surgeons in the U.S. have had a strong advocate who has been very instrumental in creating the professional climate that today’s DO’s enjoy. In 1978 the Osteopathic Physicians and Surgeons of Oregon hired Jeff to become the first non-DO executive director. He hit the deck running […]
Research Associate Professor Taylor is Professor Emeritus of Pharmaceutical and Public Health Policy at University College London (UCL), United Kingdom. His research interests have taken a tri-fold focus: the role of pharmaceuticals and pharmacy in global demographic and epidemiological transition and (universal) health care policy developments, with special reference to Europe and BRIC nations such […]